{
    "id": 25057,
    "fullName": "FGFR2 - PPHLN1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR2-PPHLN1 results from the fusion of FGFR2 and PPHLN1 (PMID: 25608663), resulting in constitutive phosphorylation of the fusion protein and activation of downstream Erk1/2 signaling, and is transforming in culture (PMID: 25608663). FGFR2-PPHLN1 has been identified in intrahepatic cholangiocarcinoma (PMID: 25608663).",
            "references": [
                {
                    "id": 3876,
                    "pubMedId": 25608663,
                    "title": "Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25608663"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2263,
        "geneSymbol": "FGFR2",
        "terms": [
            "FGFR2",
            "BBDS",
            "BEK",
            "BFR-1",
            "CD332",
            "CEK3",
            "CFD1",
            "ECT1",
            "JWS",
            "K-SAM",
            "KGFR",
            "TK14",
            "TK25"
        ]
    },
    "variant": "FGFR2 - PPHLN1",
    "createDate": "08/02/2016",
    "updateDate": "12/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 51535,
                "geneSymbol": "PPHLN1",
                "terms": [
                    "PPHLN1",
                    "CR",
                    "HSPC206",
                    "HSPC232"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 19584,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Infigratinib (BGJ398) inhibited growth of transformed cells expressing FGFR2-PPHLN1 in culture (PMID: 25608663).",
            "molecularProfile": {
                "id": 25823,
                "profileName": "FGFR2 - PPHLN1"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3876,
                    "pubMedId": 25608663,
                    "title": "Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25608663"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19585,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Infigratinib (BGJ398) inhibited viability and migration of cholangiocarcinoma cells expressing FGFR2-PPHLN1 in culture (PMID: 25608663).",
            "molecularProfile": {
                "id": 25823,
                "profileName": "FGFR2 - PPHLN1"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 4947,
                "name": "cholangiocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3876,
                    "pubMedId": 25608663,
                    "title": "Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25608663"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25823,
            "profileName": "FGFR2 - PPHLN1",
            "profileTreatmentApproaches": [
                {
                    "id": 19587,
                    "name": "FGFR2 Inhibitor",
                    "profileName": "FGFR2 - PPHLN1"
                },
                {
                    "id": 19586,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR2 - PPHLN1"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}